Mirum Pharmaceuticals's total assets for Q2 2025 were $725.83M, an increase of 5.15% from the previous quarter. MIRM total liabilities were $470.67M for the fiscal quarter, a 2.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.